<DOC>
	<DOC>NCT02385396</DOC>
	<brief_summary>The purpose of this study is to analyse the activity of myo-inositol on pregnancy rate, embryo development dynamics and oestradiol and progesterone concentration in blood serum and Superoxide Dismutase (SOD) and catalase concentration in follicular fluid of patients with Polycystic Ovary Syndrome (PCOS) undergoing Intracytoplasmic Sperm Injection (ICSI).</brief_summary>
	<brief_title>Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>ICSI treatment due to infertility PCOS patients enrolled according to the criteria established by representatives of the American Society of Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) Severe endometriosis BMI &lt;17 and &gt;30 Metabolic diseases Lowered ovarian reserve</criteria>
	<gender>Female</gender>
	<minimum_age>27 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>Infertility</keyword>
	<keyword>Myo-inositol</keyword>
	<keyword>Intracytoplasmic sperm injection</keyword>
</DOC>